BioencaS.A.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Suspended
Registry date
2022-03-22
Share capital
111 477,70 PLN
Activity description

Bioenca works on a medicine for drug-resistant epilepsy. The company also focuses on the medical use of cannabis. It is a Polish company active in epilepsy care and cannabis-based therapy.

Registered address
ul. Towarowa 9F/36, 10-416 Olsztyn, Poland
Website
bioenca.plWebsite active
Email
Email address current
Phone

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Zbigniew Opęchowski — President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board is authorised to make declarations of will on behalf of the company independently. If the management board consists of two or more members, joint action of two members of the management board or of one member of the management board jointly with a commercial proxy is required to make declarations of will on behalf of the company.

Supervisory board

Grzegorz Władysław Konrad — Supervisory Board Member
Maciej Leszek Twaróg — Supervisory Board Member
Małgorzata Maria Żmigrodzka — Supervisory Board Member

Ownership

Beneficial owners

Person
Zbigniew Opęchowski (53)

Change history

DateEvent
2024-12-31Business suspended
2022-11-22Share capital change
2022-11-22Name change
2022-03-22Entered in the register

FAQ

Last updated: 2026-07-25